Free Trial
ASX:API

Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Australian Pharmaceutical Industries logo

About Australian Pharmaceutical Industries Stock (ASX:API)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
453,647 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Receive API Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

API Stock News Headlines

What This Post-Election Shift Means for Your Investments
The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.
Elon Musk's xAI launched its own API
See More Headlines

API Stock Analysis - Frequently Asked Questions

Australian Pharmaceutical Industries Limited (ASX:API) released its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU).

Company Calendar

Last Earnings
4/17/2019
Today
11/22/2024

Industry, Sector and Symbol

Industry
Medical Equipment Wholesale
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
1,310
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.00 billion
Book Value
A$0.89 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (ASX:API) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners